Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer - Concepedia

Concepedia

Publication | Open Access

Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer

DOI Full Paper Access

46

Citations

22

References

2020

Year

Morena Fasano, Carminia Maria Della Corte, Raimondo Di Liello, Giusi Barra, Francesca Sparano, Giuseppe Viscardi, Maria Lucia Iacovino, Fernando Paragliola, Vincenzo Famiglietti, Vincenza Ciaramella,

Abstract

Cetuximab and avelumab activates NSCLC pt NK cells. Ex vivo evaluation of ADCC, circulating DNA levels and early skin toxicity may predict response to cetuximab plus avelumab in NSCLC.EUDRACT 2017-004195-58.

References

	Year	Citations

Page 1